Abstract Real-world effectiveness studies are important for monitoring performance of COVID-19 vaccination programmes and informing COVID-19 prevention and control policies. We aimed to synthesise methodological approaches used in COVID-19 vaccine effectiveness studies, in order to evaluate which

Bhutan’s national and also the oldest newspaper named ‘Kuensel’ from the Kuensel Corporation Limited published a story featuring, our support to the Bhutanese government in evaluating new vaccines through an economic evaluation, in their issue of 28th August 2017 http://www.kuenselonline.com/moh-exp

To support government decision-making to address the COVID-19 outbreak, the National Data Management Center (NDMC) of the Ethiopia Public Health Institute (EPHI) conducted a systematic review of the economic evaluations of public health measures for the prevention and control of pandemics. The study

A website offering parents advice on vaccines has been ordered to remove information about the MMR jab after claiming it could be linked to autism.Babyjabs.co.uk said the three-in-one jab may be causing “up to 10%” of autism in children in the UK.But the Advertising Standards Authority ruled the cla

The Health Intervention and Technology Assessment Program (HITAP) International Unit (HIU), Thailand was contracted by the World Health Organization to provide technical support to two local Nepalese partners, namely the Center for Molecular Dynamics – Nepal (CMDN) and Nepal Health Economics Association (NHEA), to conduct an economic burden study

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m

Department of Immunization, Vaccines and Biologicals, World Health Organization (WHO) ได้รับการสนับสนุนเงินทุนจาก Global Alliance for Vaccines and Immunization (GAVI) และ the Centers for Disease Control and Prevention (US CDC) เพื่อริเริ่มโครงการพั

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Manuel Alexander Haasis1*, Joyce Anne Ceria1, Wantanee Kulpeng2, Yot Teerawattananon2, Marissa Alejandria3 1 National Center for Pharmaceutical Access and Management (NCPAM), Department of Health, Manila, Philippines, 2 Health Intervention and Technology Assessment Program (HITAP), Department of